Navigation Links
NIH scientists reflect on gains in emerging infectious disease awareness, research and response
Date:12/11/2012

WHAT:

In a new essay, National Institute of Allergy and Infectious Diseases director Anthony S. Fauci, M.D., and David Morens, M.D., reflect on what has been learned about emerging infectious diseases (EIDs) in the two decades since a major report from the U.S. Institute of Medicine rekindled interest in this important topic.

Heightened awareness of EIDs is itself a countermeasure against disease, note the authors. The emergence of new diseases can now be monitored in real time online through Internet resources such as ProMED. In 2012 alone, such resources kept the scientific community and the public informed about the emergence in the Middle East of a novel disease-causing coronavirus; occurrences of illness at Yosemite National Park caused by a hantavirus; and the emergence in U.S. farm communities of a variant influenza virus (H3N2v) that spread from swine to people. The authors point to advances that have improved the diagnosis, treatment and prevention of EIDs. Rapid sequencing of whole genomes, for example, allows for swift identification of new disease agents. The complex interactions between disease-causing microbes and human hosts are being revealed through approaches that describe entire biological systems holistically (systems biology). The data from such studies can be used to inform the development of drugs or vaccines. Recent appreciation of the sometimes beneficial role of communities of microorganisms dwelling in the gut, mouth, skin and other niches has reshaped the standard notion of infectious diseases as a simple contest between virulent invading pathogens and the human immune system.

The scientists emphasize the need for sustained commitment to developing countermeasures for specific diseases and to basic research that will lead to a greater understanding of infectious diseases and human susceptibility.

ARTICLE:

DM Morens and AS Fauci. Emerging infectious diseases in 2012: 20 years after the Institute of Medicine report. mBio DOI: 10.1128/mBio.00494-12 (2012) (http://mbio.asm.org/content/3/6/e00494-12).

WHO:

NIAID Director Anthony S. Fauci, M.D., and David M. Morens, M.D., senior advisor to the NIAID Director are available to comment.

CONTACT:

To schedule interviews, please contact Anne A. Oplinger, (301) 402-1663, aoplinger@niaid.nih.gov.


'/>"/>

Contact: Anne A. Oplinger
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Related medicine news :

1. 2 UT Southwestern scientists honored as rising stars in Texas research
2. Drug resistant leukemia stem cells may be source of genetic chaos, Temple scientists find
3. UCLA cancer scientists identify liposarcoma tumors that respond to chemotherapy
4. To make old skin cells act young again, boost their surroundings, U-M scientists show
5. Temple scientists target DNA repair to eradicate leukemia stem cells
6. Green scientists propose safety testing system for development of new chemicals
7. Scientists discover mechanism that could reduce obesity
8. Johns Hopkins scientists pair blood test and gene sequencing to detect cancer
9. Scripps Florida scientists uncover a novel cooperative effort to stop cancer spread
10. Scientists at the Institute of Molecular Biology identify key event for sex determination
11. Scientists win funding to study new treatment for severe chronic pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... ... Doctors on Liens is continuing its steady expansion of medical specialties throughout ... North Valley Eye Medical Group in Mission Hills . Eye injuries and vision ... cases. These injuries have a major impact on the quality of life of ...
(Date:2/22/2017)... ... February 22, 2017 , ... The first-ever ... as organizations, advocates, and individuals join together to increase recognition about the risks ... save lives. , “Today we mark a nationwide movement to raise awareness about ...
(Date:2/22/2017)... ... 22, 2017 , ... Bellus Medical, a leader in medical ... delivery of Platelet Rich Plasma (PRP). PRP systems are used by physicians in ... synthesis and provide a faster and more efficient healing process. There are many ...
(Date:2/22/2017)... ... 22, 2017 , ... The SeniorCare Investor will host an important webinar— Seniors ... 2017, at 1:00 PM ET. A recording of the webinar will also be made ... , If you want to find out what really happened in the seniors housing ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... suffer from combat-related PTSD. , Established in 1977, our organization was at the ... of military returning to civilian life were evident and served as the catalyst ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... , Feb. 22, 2017 IRIDEX Corporation ... will release financial results for the fourth quarter and ... 8, 2017.  The Company,s management team will host a ... 5:00 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
(Date:2/22/2017)... astic drugs develop from traditional single antineoplastic drug towards ... at multiple links. Research and development of antineoplastic drugs ... Download the full report: https://www.reportbuyer.com/product/4696059/ ... new tumors in China every ... industrialization and lifestyles changed by factors like urbanization, malignant ...
(Date:2/22/2017)... Summary Provides understanding and access ... agreements entered into by the worlds leading healthcare companies. ... Description The Global Non-Small Cell Lung Cancer Partnering Terms ... to partnering deals and agreements entered into by the ... partnering deals - Top deals by value ...
Breaking Medicine Technology: